[go: up one dir, main page]

ATE401327T1 - Pyrroloimidazolderivate ,verfahern zu ihrer herstellung, diese enthaltende zusammensetzungen, und ihre verwendung als nootropika - Google Patents

Pyrroloimidazolderivate ,verfahern zu ihrer herstellung, diese enthaltende zusammensetzungen, und ihre verwendung als nootropika

Info

Publication number
ATE401327T1
ATE401327T1 AT04741432T AT04741432T ATE401327T1 AT E401327 T1 ATE401327 T1 AT E401327T1 AT 04741432 T AT04741432 T AT 04741432T AT 04741432 T AT04741432 T AT 04741432T AT E401327 T1 ATE401327 T1 AT E401327T1
Authority
AT
Austria
Prior art keywords
nootropices
production
compositions containing
containing same
action
Prior art date
Application number
AT04741432T
Other languages
English (en)
Inventor
Carlo Farina
Stefania Gagliardi
Carlo Parini
Marisa Martinelli
Carla Ghelardini
Original Assignee
Nikem Research Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nikem Research Srl filed Critical Nikem Research Srl
Application granted granted Critical
Publication of ATE401327T1 publication Critical patent/ATE401327T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04741432T 2003-03-24 2004-03-22 Pyrroloimidazolderivate ,verfahern zu ihrer herstellung, diese enthaltende zusammensetzungen, und ihre verwendung als nootropika ATE401327T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000573A ITMI20030573A1 (it) 2003-03-24 2003-03-24 Composti ad azione nootropica, loro preparazione,

Publications (1)

Publication Number Publication Date
ATE401327T1 true ATE401327T1 (de) 2008-08-15

Family

ID=33042696

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04741432T ATE401327T1 (de) 2003-03-24 2004-03-22 Pyrroloimidazolderivate ,verfahern zu ihrer herstellung, diese enthaltende zusammensetzungen, und ihre verwendung als nootropika

Country Status (24)

Country Link
US (3) US7544705B2 (de)
EP (1) EP1608655B8 (de)
JP (1) JP4920408B2 (de)
CN (1) CN100522963C (de)
AT (1) ATE401327T1 (de)
AU (1) AU2004224087B2 (de)
BR (1) BRPI0408601A (de)
CA (1) CA2520008C (de)
CY (1) CY1108401T1 (de)
DE (1) DE602004015089D1 (de)
DK (1) DK1608655T3 (de)
EA (1) EA009558B1 (de)
ES (1) ES2309534T3 (de)
HK (1) HK1083837A1 (de)
HR (1) HRP20050833A2 (de)
IT (1) ITMI20030573A1 (de)
NO (1) NO20054898L (de)
NZ (1) NZ543154A (de)
PL (2) PL1608655T3 (de)
PT (1) PT1608655E (de)
RS (1) RS20050725A (de)
SI (1) SI1608655T1 (de)
WO (1) WO2004085438A2 (de)
ZA (1) ZA200508578B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20030573A1 (it) * 2003-03-24 2004-09-25 Nikem Research Srl Composti ad azione nootropica, loro preparazione,
EP1925304A1 (de) * 2006-11-15 2008-05-28 Nikem Research S.R.L. Pyrrolo[1,2-a]imidazoledione zur Behandlung von durch Chemotherapie ausgelöster peripherer Neuropathie
AU2012201853B2 (en) * 2007-04-16 2013-06-27 Neurotune Ag Use of dimiracetam in the treatment of chronic pain
ITMI20070770A1 (it) 2007-04-16 2008-10-17 Brane Discovery S R L Impiego di dimiracetam nel trattamento del dolore cronico
DK2346500T3 (en) 2008-10-16 2017-07-17 Univ Johns Hopkins Methods and compositions for improving cognitive function
US9125898B2 (en) 2008-11-14 2015-09-08 Neurotune Ag Acetam derivatives for pain relief
AU2011215870B2 (en) * 2010-02-09 2016-01-28 The Johns Hopkins University Methods and compositions for improving cognitive function
ES2473271T3 (es) * 2010-07-26 2014-07-04 Neurotune Ag Proceso de preparación de dimiracetam
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia
US11160785B2 (en) 2013-03-15 2021-11-02 Agenebio Inc. Methods and compositions for improving cognitive function
EP2968237A4 (de) 2013-03-15 2016-08-31 Univ Johns Hopkins Verfahren und zusammensetzungen zur verbesserung der kognitiven funktion
MX2017014774A (es) 2015-05-22 2018-02-15 Agenebio Inc Composiciones farmaceuticas de levetiracetam de liberacion extendida.
JOP20190251A1 (ar) 2017-05-31 2019-10-21 Metys Pharmaceuticals AG تركيبات تآزرية تشتمل على (r)-ديميراسيتام (1) و(s)-ديميراسيتام (2) بنسبة غير راسيمية
HUE062575T2 (hu) 2018-12-04 2023-11-28 Metys Pharmaceuticals AG (R)-2-(2-oxopirrolidin-1-il)-butánamidot és (S)-2-(2-oxopirrolidin-1-il)-butánamidot nem-racém arányban tartalmazó szinergetikus kompozíciók
AU2019394706A1 (en) 2018-12-04 2021-05-20 Metys Pharmaceuticals AG Synergistic compositions comprising R-2-(substituted-sulfonyl)-hexahydro-pyrrolo[1,2-a]pyrazin-6(2H)-ones and S-2-(substituted-sulfonyl)-hexahydro-pyrrolo[1,2-a]pyrazin-6(2H)-ones in a non-racemic ratio

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582838A (en) * 1984-08-24 1986-04-15 Warner-Lambert Company Derivatives of dihydro-1H-pyrrolo[1,2-c]imidazol-3,5-dione as cognition activators
IT1233860B (it) * 1988-02-08 1992-04-21 Isf Spa Derivati del peridroazacicloalca (1,2-a) imidazolo ad attivita' nootropa
US5200406A (en) * 1988-02-08 1993-04-06 I.S.F. Societa Per Azioni Pharmaceutically useful 2,5-dioxo-1H-octahydroimidazo[1,2-A]azepines
JP3400466B2 (ja) * 1991-10-28 2003-04-28 日本水産株式会社 高純度エイコサペンタエン酸またはそのエステルの製造方法
GB9123641D0 (en) * 1991-11-07 1992-01-02 Isf Spa Process
ITMI20030573A1 (it) * 2003-03-24 2004-09-25 Nikem Research Srl Composti ad azione nootropica, loro preparazione,
EP1925304A1 (de) * 2006-11-15 2008-05-28 Nikem Research S.R.L. Pyrrolo[1,2-a]imidazoledione zur Behandlung von durch Chemotherapie ausgelöster peripherer Neuropathie

Also Published As

Publication number Publication date
JP2006523198A (ja) 2006-10-12
ITMI20030573A1 (it) 2004-09-25
US20070027137A1 (en) 2007-02-01
RS20050725A (en) 2007-11-15
US7544705B2 (en) 2009-06-09
PL378939A1 (pl) 2006-06-12
JP4920408B2 (ja) 2012-04-18
SI1608655T1 (sl) 2008-12-31
US20100173945A1 (en) 2010-07-08
PL1608655T3 (pl) 2009-03-31
BRPI0408601A (pt) 2006-03-07
WO2004085438A2 (en) 2004-10-07
EP1608655B8 (de) 2008-10-15
NO20054898L (no) 2005-10-24
CY1108401T1 (el) 2014-02-12
EA200501501A1 (ru) 2006-04-28
WO2004085438A3 (en) 2004-11-25
US7732473B2 (en) 2010-06-08
EP1608655A2 (de) 2005-12-28
US20090163565A1 (en) 2009-06-25
AU2004224087B2 (en) 2010-04-01
ES2309534T3 (es) 2008-12-16
EA009558B1 (ru) 2008-02-28
ZA200508578B (en) 2007-04-25
PT1608655E (pt) 2008-10-07
CN100522963C (zh) 2009-08-05
AU2004224087A1 (en) 2004-10-07
NZ543154A (en) 2008-03-28
DK1608655T3 (da) 2008-11-03
CA2520008A1 (en) 2004-10-07
HRP20050833A2 (en) 2006-02-28
EP1608655B1 (de) 2008-07-16
CA2520008C (en) 2011-08-23
CN1756757A (zh) 2006-04-05
DE602004015089D1 (de) 2008-08-28
HK1083837A1 (en) 2006-07-14

Similar Documents

Publication Publication Date Title
HK1083837A1 (en) Pyrroloimidazole derivatives, their preperation, pharmaceutical compositions containing them, and their use as nootropic agents
EA200600294A1 (ru) [1,8] нафтиридин-2-оны и родственные соединения для лечения шизофрении
EA200601212A1 (ru) Ингибиторы фосфодиэстеразы, получение и их терапевтическое применение
MA28241A1 (fr) Derives d'indole hydroxyethylamine tricycliques et leur utilisation dans le traitement de la maladie d'alzheimer
IS7925A (is) Hýdroxýetýlamínafleiður til að meðhöndla Alzheimers-sjúkdóm
NO20060446L (no) Trisykliske delta-opioidmodulatorer
MXPA05007462A (es) Derivados de pirrolopiridazina.
MY148145A (en) Methods of synthesis and/or purification of diaminophenothiazinium compounds
DE10337184A1 (de) Substituierte 3-Pyrrolidin-Indol-Derivate
MX2008002234A (es) Inhibidores de sulfonamida n-biciclico puenteados de gamma secretasa.
ATE335748T1 (de) Thienopyrimidindione und deren verwendung bei der modulierung von autoimmunerkrankungen
ATE397930T1 (de) Verwendung von oxazolidinon-chinolin-hybrid- antibiotika zur behandlung von anthrax und anderen infektionen
PL1776349T3 (pl) Pochodne 2-amino-chinazoliny użyteczne jako inhibitory beta-sekretazy (BACE)
ATE401304T1 (de) Kationisch substituierte diphenylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
WO2006069276A3 (en) TRICYCLIC ō-OPIOID MODULATORS
MXPA05009014A (es) Antagonistas del receptor ccr-3.
ATE360424T1 (de) 2,3,4,5-tetrahydrobenzo[fö]1,4öoxazepin-5- carbonsäureamid derivate als gamma-secretase inhibitoren zur behandlung von alzheimer
DE102004016179A1 (de) Verbindungen zur Behandlung von proliferativen Prozessen
ATE432936T1 (de) Imidazotriazin verbindungen zur behandlung von krebserkrankungen
DE602004019481D1 (de) Antiandrogen-Oligonukleotide zur Behandlung von Androgen-verwandten Hautkrankheiten, diese Verbindungen enthaltende pharmazeutische Zusammensetzungen und deren Verwendung
MX2007007627A (es) Moduladores delta-opioides triciclicos.
EA200600115A1 (ru) Производные 2-аминобензойной кислоты
ATE423780T1 (de) Makrozyclen zur behandlung von krebserkrankungen
EA200600318A1 (ru) ПРОИЗВОДНЫЕ 3-НИТРОПИРАЗОЛО[1,5-a]ПИРИМИДИНОВ, СПОСОБ ИХ ПОЛУЧЕНИЯ, ЛЕКАРСТВЕННОЕ СРЕДСТВО (ВАРИАНТЫ) И СПОСОБ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С МОДУЛЯЦИЕЙ РЕЦЕПТОРА ГАМК(ВАРИАНТЫ)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1608655

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee